Technology News and Research

RSS

PTC Therapeutics achieves milestone in Schering-Plough hepatitis C collaboration

PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.

11 Aug 2009

Febit's DNA-capture method selected by NCGR to re-sequence 400 genes involved in childhood diseases

The National Center for Genome Resources (NCGR) has selected febit's DNA-capture method, HybSelect, to re-sequence the exons of genes involved in over 400 of the most devastating childhood diseases with the ultimate goal of developing genetic tests to detect carrier status for recessive genetic diseases in prospective parents.

11 Aug 2009

Seattle Genetics reaches milestone under collaboration agreement with MedImmune

Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca. The milestone was triggered by MedImmune’s initiation of a phase I clinical trial of MEDI-547, its anti-EphA2 ADC for solid tumors.

11 Aug 2009

Indian health service contemplates its role in health care reform

Indian Country Times reports on the Indian Health Service's role in national health care reform with IHS Director Dr. Yvette Roubideaux arguing that things are improving at IHS, but the agency must adapt to rapid changes in national health care reform and demonstrate willingness to improve.

11 Aug 2009

Oxygen nanosensor could improve tumor imaging

A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.

11 Aug 2009

Holography helps tackle ovarian cancer

Two University of Arizona researchers have formed a research team to design, build and evaluate two versions of an ovarian cancer medical imaging and screening instrument that will use holographic components in a new type of optical microscope.

11 Aug 2009

Major medical biller goes public as health reform raises expectations for sector

Emdeon Inc., a company that processed nearly half of all electronic medical claims in the United States last year, is going public in an IPO this week, The Wall Street Journal reports.

11 Aug 2009

Unigene Labs reports financial results for three months ended June 30, 2009

Revenue for the three months ended June 30, 2009 was $4,297,000, compared to $4,978,000 for the three months ended June 30, 2008. Revenue for both periods primarily consisted of Fortical sales and royalties, which were $3,807,000 for the three months ended June 30, 2009, and $4,110,000 for the three months ended June 30, 2008.

11 Aug 2009

Depomed reports promising results in phase I trial for DM-1992 in Parkinson’s

Depomed, Inc. (NASDAQ:DEPO) today announced that in its Phase 1 pharmacokinetic study in Parkinson’s patients, DM-1992, Depomed’s investigative novel gastric retentive extended-release formulation of levodopa/carbidopa, extended coverage above levodopa’s efficacious threshold and extended the time to peak levodopa concentration relative to currently available sustained release levodopa/carbidopa formulations.

11 Aug 2009

Eiger Biopharmaceuticals starts CLEAN-1 HCV phase 1B trial

Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.

10 Aug 2009

Stemcells, Inc. reports Q2 financials

Results for the quarter reflect the Company’s acquisition of the operations of Stem Cell Sciences Plc (SCS), a UK-based company focused on cell-based technologies for drug discovery and screening.

10 Aug 2009

Virtual heart surgery helps plan child's surgery

Researchers at the Georgia Institute of Technology, collaborating with pediatric cardiologists and surgeons at The Children’s Hospital of Philadelphia, have developed a tool for virtual surgery that allows heart surgeons to view the predicted effects of different surgical approaches.

10 Aug 2009

Clinton signs new $10 million agreement on HIV/AIDS with Angola, says U.S. 'stands ready' to work with South Africa on HIV/AIDS

Secretary of State Hillary Rodham Clinton signed a new agreement with Angola aimed at controlling the spread of HIV/AIDS, the Associated Press reports. "The Obama administration will more than double funding for Angola to combat the disease, from $7 million to $17 million," the news service writes (Lee, 8/10).

10 Aug 2009

Cephalon, Inc. completes acquisition of Arana Therapeutics

Cephalon, Inc. (Nasdaq: CEPH) announced today that it has completed its previously announced acquisition of all of the outstanding ordinary shares of Australian biotechnology company, Arana Therapeutics Limited. As a result of the acquisition, Arana is now a wholly-owned subsidiary of Cephalon.

10 Aug 2009

CDC expands existing vaccine distribution partnership with Mckesson to include H1N1 flu vaccine

McKesson Corporation (NYSE:MCK) today announced that its current partnership with the Centers for Disease Control and Prevention (CDC) has been expanded to include preparations for H1N1 flu vaccine distribution. The CDC currently has a contract with McKesson for distribution of its public-sector purchased adult and pediatric vaccines, including those distributed through the Vaccines for Children Program.

10 Aug 2009

Automated dispensing unit provides more accurate pharmacy automation

For central fill and mail order pharmacies looking to move their unit-of-use dispensing and pre-pack dispensing from A-frames to more accurate pharmacy automation, Tension International Automation Solutions (TIAS) offers the ADU-3500L. The automated dispensing unit (ADU) automates the dispensing, labeling and verification of pre-packaged products, and pharmaceutical and nutraceutical units-of-use.

10 Aug 2009

Array Biopharma reports Q4 and full year 2009 financials

Array reported revenue of $5.5 million for the fourth quarter of fiscal 2009, compared to revenue of $6.1 million for the same period in fiscal 2008. Array invested $21.3 million in proprietary research and development for the quarter to advance its seven wholly-owned drugs in clinical development and select discovery programs.

10 Aug 2009

Mal-illumination - the silent epidemic

Most of human history has witnessed people living and working outdoors during the light of day, absorbing "life-charging" full-spectrum solar energy from the sky. An average of 10 hours daily in the sunlight, 70 hours weekly, was common for eons.

10 Aug 2009

Curemark closes $6.5 million Series A round of funding

Curemark, a privately held drug research and development company, announced today that it has closed a $6.5M Series A round of funding.

10 Aug 2009

ISI to host eSolutions Conference in September 2009

Image Solutions Inc. (ISI), a leading provider of electronic submissions management and publishing solutions for the life sciences industry, has unveiled a prestigious line-up of speakers for its annual eSolutions Conference in Barcelona, Spain, this September to support an agenda aimed at reinventing the regulatory function.

10 Aug 2009